Teva Beats Merck Infringement Suit Over Valid Patent
A Delaware federal judge found Merck Sharp & Dohme Corp.'s asserted claims on its Nasonex patent valid on Wednesday, though she cleared Teva Pharmaceuticals of infringement allegations triggered by an abbreviated...To view the full article, register now.
Already a subscriber? Click here to view full article